Articles with public access mandates - Sripathi M. Sureban, M. Pharm, Ph.D.Learn more
Not available anywhere: 3
XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism
SM Sureban, R May, N Weygant, D Qu, P Chandrakesan, ...
Cancer letters 351 (1), 151-161, 2014
Mandates: US National Institutes of Health
Epigenetic Variations of Stem Cell Markers in Cancer
SM Sureban, D Qu, CW Houchen
Epigenetics and Cancer, 115-128, 2013
Mandates: US National Institutes of Health
Inhibition of Notch signaling reduces the number of surviving Dclk1+ reserve crypt 2 epithelial stem cells following radiation injury 3
NA Chandrakesan, L Li, T Barrett, CW Houchen
Mandates: US National Institutes of Health
Available somewhere: 32
DCAMKL-1 Regulates Epithelial–Mesenchymal Transition in Human Pancreatic Cells through a miR-200a–Dependent Mechanism
SM Sureban, R May, SA Lightfoot, AB Hoskins, M Lerner, DJ Brackett, ...
Cancer research 71 (6), 2328-2338, 2011
Mandates: US National Institutes of Health
Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo
SM Sureban, R May, RJ George, BK Dieckgraefe, HL McLeod, ...
Gastroenterology 134 (5), 1448-1458. e2, 2008
Mandates: US National Institutes of Health
Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively
R May, SM Sureban, N Hoang, TE Riehl, SA Lightfoot, R Ramanujam, ...
Stem cells 27 (10), 2571-2579, 2009
Mandates: US National Institutes of Health
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism
SM Sureban, R May, FG Mondalek, D Qu, S Ponnurangam, P Pantazis, ...
Journal of nanobiotechnology 9, 1-13, 2011
Mandates: US National Institutes of Health
Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe
SM Sureban, S Ramalingam, G Natarajan, R May, D Subramaniam, ...
Oncogene 27 (33), 4544-4556, 2008
Mandates: US National Institutes of Health
DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer
SM Sureban, R May, D Qu, N Weygant, P Chandrakesan, N Ali, ...
PloS one 8 (9), e73940, 2013
Mandates: US National Institutes of Health
Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism
SM Sureban, R May, S Ramalingam, D Subramaniam, G Natarajan, ...
Gastroenterology 137 (2), 649-659. e2, 2009
Mandates: US National Institutes of Health
Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells
P Chandrakesan, J Yao, D Qu, R May, N Weygant, Y Ge, N Ali, ...
Molecular Cancer 16, 1-14, 2017
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas
R May, SM Sureban, SA Lightfoot, AB Hoskins, DJ Brackett, RG Postier, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 299 (2 …, 2010
Mandates: US National Institutes of Health
Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts
N Ali, H Allam, R May, SM Sureban, MS Bronze, T Bader, S Umar, ...
Journal of virology 85 (23), 12292-12303, 2011
Mandates: US National Institutes of Health
Brief report: Dclk1 deletion in tuft cells results in impaired epithelial repair after radiation injury
R May, D Qu, N Weygant, P Chandrakesan, N Ali, SA Lightfoot, L Li, ...
Stem cells 32 (3), 822-827, 2014
Mandates: US National Institutes of Health
Identification of the putative intestinal stem cell marker doublecortin and CaM kinase‐like‐1 in Barrett's esophagus and esophageal adenocarcinoma
KJ Vega, R May, SM Sureban, SA Lightfoot, D Qu, A Reed, N Weygant, ...
Journal of gastroenterology and hepatology 27 (4), 773-780, 2012
Mandates: US National Institutes of Health
DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition
P Chandrakesan, N Weygant, R May, D Qu, HR Chinthalapally, ...
Oncotarget 5 (19), 9269, 2014
Mandates: US National Institutes of Health
Ablation of doublecortin-like kinase 1 in the colonic epithelium exacerbates dextran sulfate sodium-induced colitis
D Qu, N Weygant, R May, P Chandrakesan, M Madhoun, N Ali, ...
PLoS One 10 (8), e0134212, 2015
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis
KS Bishnupuri, Q Luo, SK Sainathan, K Kikuchi, SM Sureban, ...
Gastroenterology 138 (2), 616-626. e2, 2010
Mandates: US National Institutes of Health
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism
SM Sureban, MF Madhoun, R May, D Qu, N Ali, J Fazili, N Weygant, ...
Oncotarget 6 (35), 37200, 2015
Mandates: US Department of Veterans Affairs
Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells
D Qu, J Johnson, P Chandrakesan, N Weygant, R May, N Aiello, A Rhim, ...
PloS one 10 (2), e0118933, 2015
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program